| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/26/1994 | EP0579915A1 Pharmaceutical composition containing a-cis- o 13-cis-retinoic acid or acitretin and a vitamin D derivative |
| 01/26/1994 | EP0579791A1 Cellular composition for the treatment of human or animal organisms |
| 01/26/1994 | EP0579754A1 Use of amines to sensitize multidrug-resistant cells |
| 01/26/1994 | EP0579647A1 Anti-cancer coumpounds |
| 01/26/1994 | EP0502020B1 NOVEL BENZO [b] PHENANTHROLINE-1,7 DERIVATIVES, AND THEIR PREPARATION AND THERAPEUTICAL APPLICATIONS |
| 01/26/1994 | EP0424512B1 Antimetastatic peptides |
| 01/26/1994 | CN1081182A New substituted phenylimidazolidines, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 01/25/1994 | US5281731 Synthesis of 19-nor vitamin D compounds |
| 01/25/1994 | US5281715 Pharmaceuticals |
| 01/25/1994 | US5281710 Dynemicin analogs: synthesis, methods of preparation and use |
| 01/25/1994 | US5281702 Di-N-deacetyl-lysogangliosides |
| 01/25/1994 | US5281587 Estrone or androsterone steroid-3-thiophosphonate for treatment of estrogen dependant tumors |
| 01/25/1994 | US5281578 Pharmaceutical gallium metal complex in mixture with carrier |
| 01/25/1994 | US5281417 Administering compound BMY46164 |
| 01/25/1994 | CA1326487C Mitomycin analogs |
| 01/25/1994 | CA1326460C Regulation of cell proliferation and differentiation using peptides |
| 01/25/1994 | CA1326452C Ifosfamide-mesna lyochilizati and process for producing same |
| 01/25/1994 | CA1326441C Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer |
| 01/20/1994 | WO1994001467A1 Characterization of a novel anti-p110rb monoclonal antibody |
| 01/20/1994 | WO1994001464A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | WO1994001414A1 Uracil derivatives as enzyme inhibitors |
| 01/20/1994 | WO1994001413A1 Boronated compounds |
| 01/20/1994 | WO1994001408A1 Anilide derivatives |
| 01/20/1994 | WO1994001138A1 Covalent polar lipid-peptide conjugates for biological targeting |
| 01/20/1994 | WO1994001109A1 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents |
| 01/20/1994 | WO1994001100A1 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/20/1994 | WO1993021942A3 Use of mmp inhibitors |
| 01/20/1994 | CA2139836A1 Iracil derivatives as enzyme inhibitors |
| 01/20/1994 | CA2139633A1 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents |
| 01/20/1994 | CA2139504A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | CA2118585A1 Characterization of a novel anti-p110rb monoclonal antibody |
| 01/19/1994 | EP0579223A1 Carboxylic acid derivatives having 5 alpha-reductase inhibitory activity |
| 01/19/1994 | EP0579196A1 Glycolipid derivatives |
| 01/19/1994 | EP0578774A1 Monoclonal antibodies to stem cell factor receptors |
| 01/19/1994 | EP0578738A1 Compositions and methods for treating small cell and nonsmall cell lung cancers |
| 01/19/1994 | EP0436682B1 Sterols, esters with fatty acids and glucosides of such sterols; a method of preparation thereof; spontaneously dispersable agents containing these compounds; and the use of such agents to treat tumours |
| 01/19/1994 | EP0423262B1 Protein fraction from the photosynthesis apparatus of plants for use as an active substance in the selective destruction of cancer cells and the post-treatment of scars, keloids and inflammatory processes and pharmaceutical products containing it |
| 01/19/1994 | CN1080959A Recombinant stimulating factor of the neu receptor |
| 01/19/1994 | CN1080917A Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/19/1994 | CN1080916A Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 01/18/1994 | US5280106 Pentapeptide; collagenase inhibitor |
| 01/18/1994 | US5280035 Cycloalkylene azoles and their use as aromatase inhibitors |
| 01/18/1994 | US5280027 Anti-tumor compounds |
| 01/18/1994 | CA2100642A1 Carboxylic acid derivatives |
| 01/16/1994 | CA2100412A1 Glycolipid derivatives |
| 01/15/1994 | CA2100377A1 Bispecific antibody |
| 01/12/1994 | EP0578516A1 Optionally substituted phenylimidazolidins, process for their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 01/12/1994 | EP0578356A2 Mycoplasma protein promoting metastases and antibody against it |
| 01/12/1994 | EP0578342A2 Purification and characterization of a CSVTCG-specific tumor cell adhesion receptor |
| 01/12/1994 | EP0578278A1 Uses of IL-1 alpha |
| 01/12/1994 | EP0578083A2 Cyclic adhesion inhibitors |
| 01/12/1994 | EP0577769A1 Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors |
| 01/12/1994 | EP0577753A1 Bis-naphthalimides containing amino-acid derived linkers as anticancer agents |
| 01/12/1994 | EP0463101B1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 01/12/1994 | EP0423228B1 Immunoconjugates for cancer diagnosis and therapy |
| 01/12/1994 | EP0422109B1 Reduction of cell proliferation and enhancement of nk-cell activity |
| 01/12/1994 | EP0374184B1 Cell growth inhibitors and methods of treating cancer and cell proliferative diseases |
| 01/12/1994 | CN1080525A Pharmaceutical compositions |
| 01/11/1994 | US5278332 Ethers of myoinsitol phosphate for drugs or foods |
| 01/11/1994 | US5278307 Process for preparing 4-hydroxypyrrolo(2,3-d)pyrimidine based antifolate compounds and intermediates |
| 01/11/1994 | US5278296 Production of hydroxysteryl glycoside compounds |
| 01/11/1994 | CA2481110A1 Vitaletheine and use in cell culture and therapy |
| 01/11/1994 | CA1326037C Strobilurine derivatives, their preparation and their use |
| 01/11/1994 | CA1326020C Pharmaceutically useful michaels' addition products of unsaturated aldehydes and ketones with ascorbic acid |
| 01/11/1994 | CA1326013C Methods for synthesizing benign prostatic hypertropic agents and their intermediates |
| 01/11/1994 | CA1325977C 5-amino or substituted amino 1,2,3-triazoles useful as antiproliferative agents |
| 01/09/1994 | CA2097248A1 Substituted phenylimidazolidines, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 01/09/1994 | CA2097247A1 Phenylimidazolidines, substituted or not, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 01/06/1994 | WO1994000601A1 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
| 01/06/1994 | WO1994000580A1 Molecular cloning of the genes reponsible for collagenase production from clostridium histolyticum |
| 01/06/1994 | WO1994000573A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | WO1994000531A1 Luminescent article with high pigment to binder ratio and manufacture thereof |
| 01/06/1994 | WO1994000530A1 Luminescent article with high phosphor to binder ratio and manufacture thereof |
| 01/06/1994 | WO1994000477A1 Substituted lactose derivatives as cell adhesion inhibitors |
| 01/06/1994 | WO1994000467A1 Heteroatomic oligonucleoside linkages |
| 01/06/1994 | WO1994000465A1 Novel sucrose ligands, methods for their preparation, platinum complexes derived therefrom, and methods for their usage |
| 01/06/1994 | WO1994000429A1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs |
| 01/06/1994 | WO1994000428A1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs |
| 01/06/1994 | WO1994000419A1 Inhibitors of farnesyl protein transferase |
| 01/06/1994 | WO1994000156A1 Polymer-bound paclitaxel derivatives |
| 01/06/1994 | WO1994000141A1 Glutathione as chemoprotective agent |
| 01/06/1994 | WO1994000140A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | WO1994000136A1 A COMBINATION OF ANTI-erbB-2 MONOCLONAL ANTIBODIES AND METHOD OF USING |
| 01/06/1994 | WO1994000118A1 Production and use of imines of porphyrins |
| 01/06/1994 | WO1994000117A1 Pharmaceutical agent with antitumoral activity |
| 01/06/1994 | WO1994000116A1 Agent with adaptogenic activity |
| 01/06/1994 | WO1994000095A2 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | WO1993015207A3 Hepatitis therapeutics |
| 01/06/1994 | CA2139414A1 Novel sucrose ligands, methods for their preparation, platinum complexes derived therefrom, and methods for their usage |
| 01/06/1994 | CA2139136A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | CA2138992A1 Glutathione as chemoprotective agent |
| 01/06/1994 | CA2138989A1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs |
| 01/06/1994 | CA2138948A1 Molecular cloning of the genes responsible for collagenase production from clostridium histolyticum |
| 01/06/1994 | CA2138807A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | CA2138770A1 Heteroatomic oligonucleoside linkages |
| 01/06/1994 | CA2138645A1 Substituted lactose derivatives as cell adhesion inhibitors |
| 01/06/1994 | CA2138538A1 Production and use of imines of porphyrins |
| 01/06/1994 | CA2138389A1 Bis-(substituted-phenyl) derivatives with cytotoxic and anticancer activity |
| 01/06/1994 | CA2138124A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | CA2137455A1 Inhibitors of farnesyl protein transferase |